Seroprevalence of COVID-19 among voluntary blood donors

CONTEXT: COVID-19 usually presents with mild symptoms. No cases of transfusion – transmission of COVID-19 had been reported. Assessing the prevalence of viral infections among blood donors is essential to frame blood safety strategies. AIM: The main aim of this study is to assess the seroprevalence...

Full description

Saved in:
Bibliographic Details
Main Authors: Arumugam Pothipillai, Swathandran Hamsavardhini, Deepa Duraisamy, Lincy Thiyagarajan, Chandrasekaran Kaliyaperumal, Jyotsnaa Grace Velure Mohan Rao
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2024-01-01
Series:Asian Journal of Transfusion Science
Subjects:
Online Access:https://journals.lww.com/10.4103/ajts.ajts_91_23
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832593742397177856
author Arumugam Pothipillai
Swathandran Hamsavardhini
Deepa Duraisamy
Lincy Thiyagarajan
Chandrasekaran Kaliyaperumal
Jyotsnaa Grace Velure Mohan Rao
author_facet Arumugam Pothipillai
Swathandran Hamsavardhini
Deepa Duraisamy
Lincy Thiyagarajan
Chandrasekaran Kaliyaperumal
Jyotsnaa Grace Velure Mohan Rao
author_sort Arumugam Pothipillai
collection DOAJ
description CONTEXT: COVID-19 usually presents with mild symptoms. No cases of transfusion – transmission of COVID-19 had been reported. Assessing the prevalence of viral infections among blood donors is essential to frame blood safety strategies. AIM: The main aim of this study is to assess the seroprevalence of SARS-CoV-2 antibodies among healthy and asymptomatic voluntary blood donors by enzyme-linked immunosorbent assay (ELISA). SETTING AND DESIGN: This cross-sectional study was conducted among voluntary blood donors using a consecutive sampling technique in the Department of Transfusion Medicine, the Tamil Nadu Dr. M.G.R. Medical University, Guindy, Chennai, for 18 months. METHODS: Adhering to COVID-19 pandemic guidelines and donor eligibility criteria, blood samples collected from 500 asymptomatic unvaccinated voluntary blood donors were tested for SARS-CoV-2 (IgG + IgM + IgA and IgG) antibodies by ELISA. Adding IgA to a conventional IgM and IgG serological test improves sensitivity. STATISTICAL ANALYSIS USED: The collected donor data were analyzed with IBM SPSS Statistics software. Pearson’s Chi-square test and Fisher’s exact test were used. P = 0.05 was considered statistically significant. RESULTS: IgG seropositivity among the donors was 58.8%, and IgM + IgA seropositivity was 29.6%. There was no statistically significant difference in the COVID-19 IgG/IgM + IgA seropositivity status with age, gender, blood group, occupation, or socioeconomic status. The IgG and IgM/IgA/IgG ELISA kits showed a difference of 13 cases which could be attributed to the higher sensitivity of IgG alone ELISA kit. This increased the seroprevalence by 3%. CONCLUSION: The majority of donors were either IgG or IgM and IgA positive, despite remaining asymptomatic. The seropositivity rate coincided with the COVID-19 surge among population.
format Article
id doaj-art-d0bffd1fdcdb45d7a6b85cf2d7c98451
institution Kabale University
issn 0973-6247
1998-3565
language English
publishDate 2024-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Asian Journal of Transfusion Science
spelling doaj-art-d0bffd1fdcdb45d7a6b85cf2d7c984512025-01-20T09:39:39ZengWolters Kluwer Medknow PublicationsAsian Journal of Transfusion Science0973-62471998-35652024-01-011819710110.4103/ajts.ajts_91_23Seroprevalence of COVID-19 among voluntary blood donorsArumugam PothipillaiSwathandran HamsavardhiniDeepa DuraisamyLincy ThiyagarajanChandrasekaran KaliyaperumalJyotsnaa Grace Velure Mohan RaoCONTEXT: COVID-19 usually presents with mild symptoms. No cases of transfusion – transmission of COVID-19 had been reported. Assessing the prevalence of viral infections among blood donors is essential to frame blood safety strategies. AIM: The main aim of this study is to assess the seroprevalence of SARS-CoV-2 antibodies among healthy and asymptomatic voluntary blood donors by enzyme-linked immunosorbent assay (ELISA). SETTING AND DESIGN: This cross-sectional study was conducted among voluntary blood donors using a consecutive sampling technique in the Department of Transfusion Medicine, the Tamil Nadu Dr. M.G.R. Medical University, Guindy, Chennai, for 18 months. METHODS: Adhering to COVID-19 pandemic guidelines and donor eligibility criteria, blood samples collected from 500 asymptomatic unvaccinated voluntary blood donors were tested for SARS-CoV-2 (IgG + IgM + IgA and IgG) antibodies by ELISA. Adding IgA to a conventional IgM and IgG serological test improves sensitivity. STATISTICAL ANALYSIS USED: The collected donor data were analyzed with IBM SPSS Statistics software. Pearson’s Chi-square test and Fisher’s exact test were used. P = 0.05 was considered statistically significant. RESULTS: IgG seropositivity among the donors was 58.8%, and IgM + IgA seropositivity was 29.6%. There was no statistically significant difference in the COVID-19 IgG/IgM + IgA seropositivity status with age, gender, blood group, occupation, or socioeconomic status. The IgG and IgM/IgA/IgG ELISA kits showed a difference of 13 cases which could be attributed to the higher sensitivity of IgG alone ELISA kit. This increased the seroprevalence by 3%. CONCLUSION: The majority of donors were either IgG or IgM and IgA positive, despite remaining asymptomatic. The seropositivity rate coincided with the COVID-19 surge among population.https://journals.lww.com/10.4103/ajts.ajts_91_23covid-19seroprevalencevoluntary blood donors
spellingShingle Arumugam Pothipillai
Swathandran Hamsavardhini
Deepa Duraisamy
Lincy Thiyagarajan
Chandrasekaran Kaliyaperumal
Jyotsnaa Grace Velure Mohan Rao
Seroprevalence of COVID-19 among voluntary blood donors
Asian Journal of Transfusion Science
covid-19
seroprevalence
voluntary blood donors
title Seroprevalence of COVID-19 among voluntary blood donors
title_full Seroprevalence of COVID-19 among voluntary blood donors
title_fullStr Seroprevalence of COVID-19 among voluntary blood donors
title_full_unstemmed Seroprevalence of COVID-19 among voluntary blood donors
title_short Seroprevalence of COVID-19 among voluntary blood donors
title_sort seroprevalence of covid 19 among voluntary blood donors
topic covid-19
seroprevalence
voluntary blood donors
url https://journals.lww.com/10.4103/ajts.ajts_91_23
work_keys_str_mv AT arumugampothipillai seroprevalenceofcovid19amongvoluntaryblooddonors
AT swathandranhamsavardhini seroprevalenceofcovid19amongvoluntaryblooddonors
AT deepaduraisamy seroprevalenceofcovid19amongvoluntaryblooddonors
AT lincythiyagarajan seroprevalenceofcovid19amongvoluntaryblooddonors
AT chandrasekarankaliyaperumal seroprevalenceofcovid19amongvoluntaryblooddonors
AT jyotsnaagraceveluremohanrao seroprevalenceofcovid19amongvoluntaryblooddonors